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Folates are cofactors for biosynthetic enzymes in all
eukaryotic and prokaryotic cells. Animals cannot
synthesize folate and must acquire it from their
diet or microbiota. Previously, we showed that inhib-
iting E. coli folate synthesis increases C. elegans life-
span. Here, we show that restriction or supplemen-
tation of C. elegans folate does not influence
lifespan. Thus, folate is required in E. coli to shorten
worm lifespan. Bacterial proliferation in the intestine
has been proposed as a mechanism for the life-
shortening influence of E. coli. However, we found
no correlation between C. elegans survival and bac-
terial growth in a screen of 1,000+ E. coli deletion
mutants. Nine mutants increased worm lifespan
robustly, suggesting specific gene regulation is
required for the life-shortening activity of E. coli.
Disrupting the biosynthetic folate cycle did not
increase lifespan. Thus, folate acts through a
growth-independent route in E. coli to accelerate
animal aging.
INTRODUCTION
Both nutrition and the host-associated microbiota are thought to
impact longevity (Heintz and Mair, 2014; Rizza et al., 2014). Diet
influences the metabolism of gut microbes, which in turn can
synthesize nutrients for the host. These interactions make it diffi-
cult to unravel the contributions of diet and the gut microbiota to
long-term health (Lozupone et al., 2012). This complexity can be
addressed with model systems such as the nematode Caeno-
rhabditis elegans (Collins et al., 2008). Yet even here, there are
numerous interactions between the nutrient agar medium, the
Escherichia coli bacterial lawn, and the worm. Chemical manip-
ulations of the medium and genetic manipulations of both E. coliCell Rand C. elegans provide tools to understand these interactions
(Weinkove, 2015).
Folates in their reduced tetrahydrofolate (THF) form are
required as enzymatic cofactors in the folate cycle; a series of
metabolic steps found in all cells (including both bacteria and an-
imals) required for cell biosynthesis. Products include purines,
pyrimidines, glycine, and methionine, which are required to
generate the methyl donor molecule S-adenosyl methionine
(SAM) (Bailey and Gregory, 1999). Animals cannot synthesize fo-
lates and so obtain folates from their diets and associated mi-
crobes (Asrar and O’Connor, 2005; Lakoff et al., 2014). Our pre-
vious research showed that C. elegans lifespan is increased
when E. coli folate synthesis is disrupted either by a mutation
in the gene aroD, which is needed to make aromatic compounds
including the folate precursor para-aminobenzoic acid (PABA),
or by sulfamethoxazole (SMX), a sulfonamide drug that com-
petes with PABA for the active site of the enzyme dihydropter-
oate synthase (Virk et al., 2012). This enzyme is a key step in
folate biosynthesis and is absent from animals. C. elegans ob-
tains folates from E. coli and thus several possible mechanisms
might explain why E. coli folate synthesis affects C. elegans life-
span. Distinguishing the effects of folates in bacteria and folates
in their animal hosts is important because folate supplementa-
tion is beneficial to human health and any intervention would
need to maintain healthy levels of serum folate.
Dietary, or caloric, restriction has been shown to extend
the lifespan of C. elegans (Greer and Brunet, 2009; Mair and
Dillin, 2008). SMX does not slow E. coli growth and therefore
has no effect on food availability. Furthermore, C. elegans
grow and reproduce normally (Virk et al., 2012). Thus, a limitation
of macronutrients is an unlikely explanation. Alternatively, inhibi-
tion of E. coli folate synthesis may influence C. elegans lifespan
by limiting dietary folate and/or a specific change in folate-
dependent nutrients (Lee et al., 2015). For example, restriction
of methionine increases lifespan in rodents and influences life-
span in Drosophila (Grandison et al., 2009; Sanchez-Roman
and Barja, 2013). Mutation of C. elegans sams-1, the gene en-
coding SAM synthase, extends lifespan (Hansen et al., 2005).eports 14, 1611–1620, February 23, 2016 ª2016 The Authors 1611
The diabetes drug metformin increases C. elegans lifespan in
a manner dependent on the E. coli strain and changes in
C. elegans folate and methionine metabolism are implicated
in mediating the lifespan extension (Cabreiro et al., 2013).
Another possible explanation is that folate synthesis inhibition
increases C. elegans lifespan by altering E. coli physiology.
E. coli can accumulate in the intestine of older C. elegans adults
and because treatment of E. coliwith antibiotics or UV increases
worm lifespan, this accumulation is widely thought to accelerate
C. elegans aging (Garigan et al., 2002; Gems and Riddle, 2000;
McGee et al., 2011). More subtly, changes in bacterial toxicity
caused by changes in bacterial metabolism might influence
C. elegans aging. The E. coli ubiGmutant, which cannot synthe-
sis coenzyme Q/ubiquinone, increases worm lifespan by influ-
encing bacterial respiration rather than dietary intake of Q (Saiki
et al., 2008).
Here, we show that modulating folate uptake or the folate cy-
cle inC. elegans does not affect lifespan, suggestingE. coli folate
influences C. elegans lifespan by acting on E. coli physiology.
Apart from the Q synthesis genes and aroD (Saiki et al., 2008;
Virk et al., 2012), little is known about how E. coli genetics influ-
ences C. elegans lifespan. A genetic screen of over 1,000 E. coli
mutants shows that bacterial growth does not correlate with
C. elegans survival and only a few specific interventions increase
C. elegans lifespan, including the mutation of genes involved in
E. coli folate synthesis, but not in the E. coli folate cycle. In addi-
tion to its role in bacterial growth, we propose that folate acts to
change E. coli physiology in a way that accelerates C. elegans
aging.
RESULTS
Genetic Disruption of C. elegans Folate Uptake and
Restoration by Supplementation
To distinguish the effects of C. elegans folate from E. coli folate,
we targeted folate uptake in C. elegans. The reduced folate
carrier FOLT-1 takes up THFs across the intestinal epithelial
membrane (Balamurugan et al., 2007). The published folt-1 dele-
tion allele causes sterility, so we turned to another C. elegans
mutant predicted to disrupt folate uptake. In mammals, gluta-
mate carboxypeptidase II (GCPII) cleaves glutamates from poly-
glutamated THFs in the gut, to create monoglutamated folates
that are preferentially imported by folate carriers and trans-
porters (Halsted et al., 1998). The E. coli diet contains predomi-
nantly polyglutamated THFs (Kwon et al., 2008; Virk et al., 2012),
suggesting that C. elegans requires GCPII activity. There are
three C. elegans genes that encode a GCPII homolog (Supple-
mental Information). Animals lacking the GCPII gene gcp-2.1,
WB Gene: WBGene00020082, appear healthy and develop nor-
mally on E. coliOP50, but develop slowly and are uncoordinated
and sterile on OP50 treated with 128 mg/ml SMX (Figure 1A). This
phenotype is rescued completely by supplementation with
10 mM formyl THFmonoglutamate, a naturally occurring reduced
folate also known as folinic acid or leucovorin (Figures 1A and
1B). Folinic acid can rescue the gcp-2.1 phenotype at a 20-fold
lower concentration than can folic acid, the oxidized folate
used commonly in dietary supplements (Figure 1B). These re-
sults are consistent with the specificity of FOLT-1 for reduced fo-1612 Cell Reports 14, 1611–1620, February 23, 2016 ª2016 The Authlates (Balamurugan et al., 2007) and a role for GCP-2.1 in folate
uptake (Figure 1C).
E. coli does not have folate uptake transporters, but can
synthesize folate from the folate breakdown products PABA,
which can freely diffuse through membranes, and PAB-Gluta-
mate, which is taken up by an active transport system (Hus-
sein et al., 1998). Thus, folic acid restores folate synthesis in
an aroD mutant, most clearly at concentrations of 100 mM or
more (Virk et al., 2012). In the presence of SMX, which com-
petes with PABA for the enzyme dihydropteroate synthase,
it is likely that more folate breakdown products would be
required to restore folate synthesis. For example, PABA is
required at a concentration of 250 mM to fully reverse the life-
span extension caused by 505 mM (128 mg/ml) SMX (Virk et al.,
2012). It is unlikely that 10 mM folinic acid would provide
enough breakdown products to restore E. coli folate synthesis
in competition with 505 mM SMX. Thus, we conclude that
folinic acid rescues gcp-2.1 by directly supplementing
C. elegans folate (Figure 1C).
Modulation of C. elegans Folate Status Does Not
Influence Lifespan
Turning to effects on aging, we found that theC. elegans gcp-2.1
mutant has a similar, if not slightly shorter lifespan, than wild-
type controls (p = 0.0227; Figure 2A). Furthermore, the increased
C. elegans lifespan caused by SMX was unaffected by supple-
mentation with 10 mM folinic acid (Figure 2B). Methotrexate
(MTX), a dihydrofolate reductase inhibitor specific to animals,
inhibits theC. elegans folate cycle. 100 mg/mlMTX causes devel-
opmental defects in nuc-1mutants and is five times the concen-
tration required to cause this phenotype (Mello et al., 1991; Virk
et al., 2012). MTX did not affect the lifespan of C. elegans and
also failed to influence the lifespan of worms on SMX-treated
bacteria (Figure 2C). Together, these results suggest that
the SMX-induced lifespan increase cannot be explained by
decreased C. elegans folate uptake or impaired folate-depen-
dent C. elegans metabolism.
SMX and Kanamycin Treatment Cause an Identical
Increase in C. elegans Lifespan
Treating E. coli with ultraviolet irradiation or antibiotics in-
creases C. elegans lifespan, suggesting that E. coli possess a
life-shortening activity (Garigan et al., 2002; Gems and Riddle,
2000). We compared OP50 treated with SMX, which does not
influence E. coli viability, with OP50 treated with kanamycin, a
bacterial translation inhibitor. Addition of kanamycin to the bac-
terial lawn stops cells forming further colonies (Virk et al.,
2012). Using large cohorts, worms maintained on kanamycin-
treated bacteria showed an almost identical survival curve to
those on bacteria treated with SMX (25% increase in mean life-
span compared to wild-type, p = < 0.0001), with a small further
increase in lifespan (4%, p = 0.0008) when both drugs were
combined (Figure 2D). While there are many possible explana-
tions for this result and SMX and kanamycin have very different
targets and effects on E. coli metabolism, the lack of a sub-
stantial additive effect suggests that both drugs might inhibit
a shared downstream process that shortens C. elegans
lifespan.ors
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Figure 1. The C. elegans gcp-2.1 Folate Up-
take Mutant Is Sensitive to SMX-Treated
E. coli and Is Rescued by Folinic Acid
(A) gcp-2.1 mutants develop as wild-type worms
on untreated OP50 E. coli, but SMX treatment
delays the growth of gcp-2.1 mutants, and this
defect can be rescued by 10 mM folinic acid. The
images were taken after 48 hr of growth at 25C.
(B) Quantification of the growth, as measured by
body length. The error bars represent SD. The
gcp-2.1mutant growth on SMX is restored at 5 mM
and 10 mM folinic acid and partially with 1 mM
folinic acid (*p < 0.05, **p < 0.01, and ***p < 0.005)
(t test). Folic acid can fully rescue growth only at
250 mM.
(C) Model showing that E. coli folate synthesis
generates THFs with up to eight glutamate resi-
dues and various one carbon groups, xTHFGlu1–8
(x = methyl, formyl, methenyl, and methylene). The
C. elegans GCPII GCP-2.1 cleaves glutamate
residues from xTHFGlu2–8 to generate xTHFGlu1,
the preferred substrates of the C. elegans reduced
folate transporter FOLT-1. Folinic acid, as an
xTHFGlu1 (5-formyl THF), can be taken up directly
by FOLT-1, bypassing GCP-2.1.It Is Unlikely that E. coli Shortens Lifespan Solely
through Intestinal Accumulation
Kanamycin and similar treatments are thought to increase
C. elegans lifespan by preventing E. coli accumulation in the in-Cell Reports 14, 1611–1620, Ftestinal lumen (Garigan et al., 2002). To
test whether SMX prevents accumula-
tion, we performed lifespan experiments
with worms maintained on E. coli OP50
expressing GFP. These fluorescent bac-
teria could be observed accumulating in
live worms from the beginning of adult-
hood through to death. A long pass green
filter, which allows red light through, was
used to distinguish GFP-expressing
E. coli from gut autofluorescence (Fig-
ure S1). This distinction is harder to
make using the narrow band green filters
employed in most studies of GFP-ex-
pressing bacteria. We detected accumu-
lation of bacteria in someworms from day
5 of adulthood onward. However, many
worms did not appear to accumulate
bacteria at all. Approximately 50% of
recently dead worms showed no visible
accumulation (Figure 3A), suggesting
that bacterial accumulation did not
contribute to their death. This heteroge-
neity in accumulation is missed when
groups of worms rather than individuals
are assessed (Gomez et al., 2012; Por-
tal-Celhay et al., 2012). SMX decreased
the number of worms that died with bac-
terial accumulation, but did not preventaccumulation from occurring in all animals. Across the whole life-
span, SMX delayed the onset of bacterial accumulation, but did
not prevent it (Figure 3B). SMX causes the GFP expressing OP50
E. coli to appear brighter than in untreated conditions, confirmingebruary 23, 2016 ª2016 The Authors 1613
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Figure 2. Lifespan Analyses of Perturba-
tions to C. elegans Folate and Comparison
of SMX and Kanamycin Treatment
(A) The gcp-2.1(ok1004)mutant does not increase
lifespan.
(B) 10 mM folinic acid does not affect the lifespan
extension caused by 128 mg/ml SMX.
(C) MTX has no effect on C. elegans lifespan.
(D) Kanamycin and SMX have a very similar effect
on C. elegans lifespan. See Table S1 for lifespan
conditions and statistics.that these bacteria are capable of producing increased protein.
SMX prolonged the time that C. elegans stay mobile, consistent
with a decrease in the rate of aging (Figure 3C). The structure and
function of the C. elegans intestine declines with age. Thus, like
motility, bacteria accumulation is a biomarker, but not neces-
sarily a cause, of aging.
E. coli Mutants Influence C. elegans Lifespan
Independently of E. coli Growth
To further understand how E. coli influence C. elegans lifespan,
we conducted a screen of over 1,000 E. coli K12 mutants from
the Keio collection (Baba et al., 2006). We tested deletions in
all non-essential genes predicted to encode enzymes in the
folate cycle or related pathways (25 genes; Table S2) and dele-
tions of 981 randomly selected genes of known function (Exper-
imental Procedures; Table S2). Scoring across the lifespan is
impractical for a large-scale screen, so we scored survival at a
single time point (day 11/12) close to the median lifespan. This
strategy allows greater statistical power than scoring near the
end of the survival curve and the identification of strains that
shorten, as well as extend, C. elegans lifespan.
The mutants were scored in batches. Each batch contained
several mutants and three wild-type strains. The distribution in
survival shown by these controls did not differ from the distribu-
tion across all mutants tested, suggesting that mutating single
E. coli genes had no detectable large-scale effect on C. elegans
lifespan (Supplemental Information; Figure S2). To account for
batch-to-batch variation, we subtracted the mean survival of
the wild-type in a batch, SW, from the survival of each mutant
SM in that batch (Supplemental Information). SM - SW revealed
a narrower distribution and a set of candidates for strains that
increased C. elegans lifespan (Figure S2). Using growth data
from Baba et al. (2006), we found no correlation between strain1614 Cell Reports 14, 1611–1620, February 23, 2016 ª2016 The Authorsgrowth and survival of C. elegans (Fig-
ure 4A), suggesting that E. coli growth
rate does not influence C. elegans aging.
Nine E. coli Mutants Robustly
Increase C. elegans Lifespan
To be confident of identifying individual
mutants that increased C. elegans life-
span, we repeated the screen for the 67
strains that caused worms to survive at
least 15%more than on the control strain.
We undertook full lifespan analysis of the22 strains that passed this second round. Finally, we retested the
11 strains that passed this third round and included full lifespan
analysis of the strains with the mutation complemented by the
wild-type E. coli gene. This step ruled out lifespan increases
from spontaneous second-site mutations (Supplemental Infor-
mation). There were nine deletions that passed this final test,
representing less than 1% of genes tested.
Three of the identified mutants (metL, ihfA, and ihfB) caused
the bacterial lawn to appear more liquid than normal. This envi-
ronment would have a strong influence on C. elegans physiology
(Lewis and Fleming, 1995). The other mutants discovered had no
visible effect on the E. coli lawn and so are more likely to influ-
ence lifespan through biological, rather than physio-chemical
mechanisms. These mutants included a deletion of rpoS, a sta-
tionary phase sigma factor. This transcription factor regulates
over 200 genes in response to low nutrients or other stresses
(Battesti et al., 2011). Other deletions that extended lifespan
included tatC, a gene encoding a component of the twin arginine
translocation pathway, which transports folded proteins to the
periplasm (Stanley et al., 2001), ompA, an abundant constituent
of the outer membrane (Smith et al., 2007), and znuB, which en-
codes part of the ZnuABC zinc transporter, needed to take up
zinc at low concentrations (Patzer and Hantke, 1998). Finally,
we isolated deletions in pabA and pabB (Figure 4B). These genes
encode two enzymes that associate and catalyze key steps in
PABA synthesis (Green et al., 1996). In summary, the screen
underlined the importance of E. coli folate synthesis in
C. elegans lifespan regulation and identified other genes with
diverse functions.
Apart from the pabA and pabB mutants, the mutants grow
slower on the petri dish than the wild-type strain (Figure S3A).
There was a positive, but not significant, correlation between
extent of the lifespan extension and the growth rate of the strain
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Figure 3. Intestinal Accumulation of Bacteria Does Not Occur in All Animals and Is Not Prevented by SMX
(A) Accumulation in recently dead animals as assessed by visualizing E. coli GFP in the intestinal lumen. The data are pooled from two biological replicates.
(B) Numbers of alive worms at indicated time points with classification of accumulation.
(C)Motility analysis of glp-4(bn2)worms onOP50 treatedwith 0, 16 mg/ml, and 128 mg/ml SMX. Eachwormwas scored as belonging tomotility class A (constantly
moving), B (moves when prodded), or C (twitches only) as described (Herndon et al., 2002).(Figure S3B). We noticed that C. elegans spent more time on the
bacterial lawn if the E. coli strain was one of the life-extending
mutants or had been treated with SMX (Figure S3C). SMX treat-
ment of OP50 also produced a similar decrease in aversion.
Thus, the increased lifespan of C. elegans is not caused by
decreased exposure to food or to E. coli. C. elegans avoids toxic
bacteria, and this avoidance is thought to be triggered by
perception of disruption to worm metabolism caused by bacte-
rial toxins (Melo and Ruvkun, 2012). Thus, the mutations isolated
in the screen, or chemical inhibition of folate synthesis, may re-
move toxicity from E. coli.Cell RDisruption of the E. coli Folate Cycle Does Not Increase
C. elegans Lifespan
Although the identification of pabA and pabB was consistent
with E. coli folate synthesis inhibition increasing C. elegans life-
span, we were surprised that no genes involved in the folate
cycle or related pathways were identified. An exception was
metL, which encodes an enzyme needed in two early stages
of methionine biosynthesis. However, deletions in other methi-
onine synthesis genes did not have a lifespan phenotype.
Because of the variation found in the screen, we wanted to
make sure that we had not missed any folate-related genes.eports 14, 1611–1620, February 23, 2016 ª2016 The Authors 1615
AB
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Figure 4. A Screen of E. coli Deletion Mu-
tants for C. elegans Survival Identified Nine
Mutants that Robustly Extend Lifespan
(A) No correlation between growth of mutant
strains in LB (Baba et al., 2006) and normalized
C. elegans survival at day 11 or 12. The mutants
that increase lifespan after the fourth round of the
screen are indicated.
(B) pabA and pabB mutants increase C. elegans
lifespan, and this increase is reversed by gene
complementation. See Table S1 for details.
(C) Mean lifespan (with SD) at various concentra-
tions of PABA on defined media plates, comparing
worms on the E. coli pabA mutant with worms on
WT E. coli. At 0.1 and 0.2 mM PABA, the lifespans
on pabA and wild-type E. coli are significantly
different (see Results and Table S1 for details). The
error bars represent SD.We performed full lifespan analysis on E. coli mutants in 23
non-essential genes involved in the folate cycle or related
metabolic pathways. None of these mutants extended lifespan
apart from a small, but significant, effect of a deletion of glyA
(Table S1). Thus E. coli folate synthesis, but not the folate cy-
cle, which is needed for E. coli growth, limits C. elegans
lifespan.1616 Cell Reports 14, 1611–1620, February 23, 2016 ª2016 The AuthorsC. elegans Lifespan Can Be Altered
through the Availability of PABA to
E. coli
Folate synthesis is essential for E. coli
growth because E. coli cannot take up
intact folate. However, SMX or mutation
of pabA or pabB do not decrease E. coli
growth rate under the conditions that
they increase C. elegans lifespan (Virk
et al., 2012) (Figure S3A). Thus, these in-
terventions must only remove folate in
excess of that required for E. coli growth.
To understand the relative levels at which
folate synthesis is required to limit lifespan
compared to requirements for growth, we
took advantage of the fact that PABA syn-
thesis in E. coli can be bypassed by add-
ing exogenous PABA, which can diffuse
across membranes and that C. elegans
cannot make folate from PABA. The
growth of pabA and pabB mutants on
peptone-based NGM, suggests this me-
dium contains a source of PABA. To re-
move thisPABAwhileminimizingchanges
to the nutritional conditions, we replaced
peptonewith a definedmix of amino acids
based on the composition of peptone, an
undefined digest of soy protein (Supple-
mental Information). When subcultured
from the rich lysogeny broth (LB) broth,
the pabA and pabB mutants grow well
on this defined medium. However, afterseveral generations of subculture in the defined medium, the
pabA mutant was unable to grow without the addition of PABA.
Growth was restored by as little as 50 nM PABA, whereas
100 mM folinic acid only incompletely rescued growth
(Figure S4A).
We tested how modulating E. coli folate synthesis influenced
C. elegans lifespan by maintaining worms on the pabA mutant
grown on defined medium supplemented with a range of PABA
concentrations. Before seeding, the pabA mutant was cultured
in liquid defined medium containing 0.2 mM PABA. Subsequent
growth of the pabA and wild-type bacterial lawn was the same
at all PABA concentrations (Figure S4B). However, on medium
supplementedwith 0.1 mMPABA,C. elegans on the pabAmutant
lived 39% longer than worms on wild-type bacteria (p = <
0.0001), or 50% longer than worms on pabA bacteria supple-
mented with 1 mM PABA (p = < 0.0001; Figure 4C). Supplemen-
tation of pabA E. coli with 0.2 mM PABA gave an intermediate
result (28% increase, p = 0.0009, compared to 1 mM PABA).
Increasing the concentration to 100 mM PABA did not decrease
lifespan (Figure 4C) on either pabA or thewild-type bacteria, sug-
gesting that PABA is not toxic. Rather, C. elegans lifespan is
increased when excess folate synthesis is removed.
DISCUSSION
C. elegans Folate and C. elegans Lifespan
Inhibiting E. coli folate synthesis decreases C. elegans folates
(Virk et al., 2012), but we have shown that these changes in
C. elegans folate are not responsible for the increased lifespan.
Lifespan is also unaffected by C. elegans folate cycle inhibition,
by MTX (Figure 2C), or by supplementation of vitamin B12,
which is required for a key step in the folate cycle (Watson
et al., 2014).
Intestinal Accumulation of E. coli: a Cause or
Consequence of C. elegans Aging?
Our analysis of accumulation of E. coli in the intestines of individ-
ual animals (Figure 3) does not exclude accumulation as the
mechanism by which folate synthesis influences lifespan, but
our data are also consistent with intestinal accumulation of
E. coli being a consequence, rather than a cause, of intestinal ag-
ing. The intestine loses its structure early in aging worms (Hern-
don et al., 2002; McGee et al., 2011) and an age-related delay in
the passage of E. coli caused by decreased pharyngeal pump-
ing, decreased defecation, or breakdown in lumenal structure,
would likely lead to bacterial accumulation. To our knowledge,
it has never been demonstrated that preventing bacterial accu-
mulation increases C. elegans lifespan. Electron microscopy
studies have failed to find evidence of E. coli OP50 invasion in
theC. elegans intestine (McGee et al., 2011) (David Hall, personal
communication) and strains of E. coli used in C. elegans exper-
iments lack the O-antigen needed for invasive pathogenesis
(Browning et al., 2013). Through increased contact with intestinal
cells, accumulation in the intestine may enhance other mecha-
nisms by which E. coli are pathogenic, thus accelerating a cycle
of functional loss in the aging intestine.
Second, we uncoupled the effects of E. coli growth from the
E. coli activity that accelerates aging in C. elegans. Though
SMX does not slow E. coli growth, we suggest it prevents a pro-
cess that is also prevented by kanamycin. This process might be
a factor that is induced by high folate levels and requires kana-
mycin-sensitive translation. The E. coli screen showed that life-
span is increased by only a fewmutations, while manymutations
slow E. coli growth without extending C. elegans lifespan. Thus,
an alternative to the growth-dependent model is that a specificCell RE. coli activity shortens lifespan, and this activity is blocked by
treatment with kanamycin and other antibiotics.
How E. coli Influences C. elegans Aging
The comparison with kanamycin suggests that inhibiting folate
synthesis removes a pro-aging activity rather than producing
an anti-aging activity. A common factor of E. coli genes isolated
in the screen such as pabA, pabB, rpoS, tatC, znuB, and ompA,
is that they reduce virulence when mutated in a wide range of
pathogenic bacteria (Brown and Stocker, 1987; Dong and
Schellhorn, 2010; Gabbianelli et al., 2011; Ochsner et al., 2002;
Teng et al., 2006). Lab strains of E. coli used for C. elegans cul-
ture do not have known virulence factors, but the genes isolated
in the screenmight regulate other, as yet unknown, factors with a
milder, long-term effect on their hosts. The decreased aversion
to E. coli mutants identified in the screen, or to E. coli treated
with SMX, is consistent with the removal of a toxin (Figure S3C)
(Melo and Ruvkun, 2012). It is likely that some of the many pep-
tides and compounds secreted by E. coli are toxic to C. elegans.
These products may or may not influence lifespan. This study
suggests that E. coli shorten C. elegans lifespan through a
form of toxin-based virulence that is milder than observed with
human pathogens, but may nevertheless be important for
chronic disease and aging.
It is interesting to note that many E. coli genes and processes
were not found to increase C. elegans lifespan robustly in the
screen. Surprisingly, genes involved in ubiquinone synthesis or
respiration were not found (Saiki et al., 2008), although the
Keio ubiG mutant did not grow sufficiently to be included in
the screen. The E. coli genes of unknown function, which consti-
tute over a third of the mutant collection (Baba et al., 2006), were
not screened and may be important for interactions with the
host by, for example, synthesizing as yet uncharacterized
toxins.
The Role of Bacterial Folate
Our work suggests that in bacteria, folate has functions beyond
its role in biosynthetic one-carbonmetabolism.Mutation of pabA
or pabB attenuates virulence in invasive bacteria, and the
accepted explanation is that these mutants cannot grow in
mammalian cells that lack PABA (Brown and Stocker, 1987; Chi-
malapati et al., 2011). However, another explanation is that these
mutants are less able to produce toxins. Likewise, sulfonamides,
which are less effective than most antibiotics in stopping bacte-
rial growth, may be effective by preventing toxicity rather than
growth. RpoS is an E. coli sigma factor activated in stationary
phase to coordinate a global stress response, which includes
increased virulence. Of the hundreds of genes reported to be un-
der RpoS transcriptional control, pabA in E. coli (Weber et al.,
2005) and pabB in Bacillus subtilis (Eymann et al., 2002) have
been implicated in microarray experiments. Thus, folate synthe-
sis may be stimulated by RpoS activity.
Possible Implications for Human Aging and Disease
We have presented evidence that E. coli accelerates C. elegans
aging independently ofE. coli growth andC. elegans folatemeta-
bolism. If a similar relationship existed in the human gut, molec-
ular characterization of this mechanism may uncover targets toeports 14, 1611–1620, February 23, 2016 ª2016 The Authors 1617
intervene in aging and chronic disease. Chronic conditions such
as obesity and inflammatory bowel disease are characterized by
a dysbiosis of the microbiota, leading to an overgrowth of
gamma proteobacteria, such as E. coli. (Winter and Ba¨umler,
2014). Interestingly, small intestine bacterial overgrowth leads
to increased levels of serum folate, originating from dominating
opportunistic bacteria (Camilo et al., 1996; Lakhani et al.,
2008). Dysbiosis and the consequent overabundance of gamma
proteobacteria may be an important factor in aging (Clark et al.,
2015). This study shows that bacteria folate synthesis can be tar-
geted without compromising host folate status, which can be
maintained by selective supplementation.
EXPERIMENTAL PROCEDURES
C. elegans Strains
N2 (wild-type), SS104 glp-4(bn2), UF208 (wild-type), and UF209 gcp-
2.1(ok1004). See Supplemental Information for gcp-2.1 analysis.
E. coli Strains
OP50 ura (Brenner, 1974), OP50-GFP (containing plasmid pFPV25.1) (Lab-
rousse et al., 2000), BW21153 (Keio collection wild-type), and WT Kan:
BW21153 pGreen 0029 (Kan+). Strains from Keio collection as listed (Table
S2). Keio strains transformed with complementation plasmids (Tables S1
and S3).
Culture Conditions
NGM was prepared using high purity agar as described (Virk et al., 2012). As
necessary, 25 mg/ml carbenicillin was added to maintain plasmid selection
(OP50-GFP and complemented Keio mutants). Kanamycin was added after
24 hr of bacterial growth as described (Garigan et al., 2002). Folinic acid, folic
acid, and MTX were from Schircks Laboratories. For the defined media,
peptone was replaced by purified amino acids (Supplemental Information)
and 0.23 trace metals (Studier, 2005). Calcium chloride was omitted as it is
in the trace metals.
Lifespan Analysis
Survival analyses were performed as described (Virk et al., 2012). Worms
were cultured at 15C and shifted to 25C at the L3 stage. At 25C, E. coli
metabolism is more active than at lower temperatures (Virk et al., 2012). At
the L4/young adult stage, animals were placed on bacteria under the exper-
imental conditions. All lifespan data is in Table S1. Statistical significance
was determined using log rank and Wilcoxon tests of the Kaplan-Meier sur-
vival model.
GFP Bacterial Accumulation Assay
Worms were prepared and set up as for lifespan analysis using OP50-GFP.
From day 5, using a Leica M165 FL stereomicroscope with a GFP2 filter with
a 510 nm+ long pass emission spectrum, individual animals were scored every
2 days for survival and as having no accumulation, partial accumulation, or full
accumulation (Figure S1).
Motility Assay
Animals were prepared as for lifespan analysis as described, with 16 plates per
condition used and ten worms per plate. Animals were classified as described
(Herndon et al., 2002).
C. elegans Growth/Body Size Analysis
Animals were imaged after 2 days of 25C growth after a synchronized egg lay.
Images were analyzed for body length as described in Supplemental
Information.
Screening Method
See Supplemental Information.1618 Cell Reports 14, 1611–1620, February 23, 2016 ª2016 The AuthGene Complementation of Keio Mutants
The relevant genomic region was PCR amplified from BW21153 using primers
with restriction sites (Table S3), cloned into the low copy pMMB67EH AmpR
plasmid (Virk et al., 2012), and transformed into the relevant mutant strain.
The plasmid was used as a control.
Measuring E. coli Lawn Growth
To quantify bacteria in bacterial lawns, 2 ml of M9 was added to a 6 cm plate.
The lawn was scraped off with a glass scraper. The liquid was then removed to
a fresh tube. The total volume of the removed liquid was multiplied by the
OD600 after a 5-fold dilution to generate a relative measure of bacteria.
Aversion Assay
Aversion was measured as number of worms off the lawn/total number of
worms as described in Melo and Ruvkun (2012).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.01.051.
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